Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
MagicMed to Be Acquired by Nasdaq-Listed Company [Psilocybin Alpha]
May 24, 2021
Enveric Biosciences Buys MagicMed In All Stock Deal Valued At $30 Million [The Green Market Journal]
May 24, 2021
MagicMed: Finding the Derivative with Dr. Joseph Tucker [Psychedelic Invest]
May 24, 2021
Enveric Biosciences Acquires Psychedelic Drug Discovery Platform MagicMed Industries [Psychedelic Spotlight]
May 24, 2021
Enveric Moves to Acquire MagicMed, Form Latest Nasdaq-Listed Psychedelics Company [Truffle Report]
May 24, 2021
Enveric Biosciences Buys MagicMed In All Inventory Deal Valued At $30 Million [Marijuana Mag]
May 24, 2021
Oncology Peer Review On-The-Go: 1-on-1 with David Johnson: Enveric’s Endocannabinoid Products for Glioblastoma [Cancer Network]
April 13, 2021
Happy Employees = Happy Shareholders [Fortune]
April 13, 2021
Enveric Biosciences CEO Describes How the Group Has ‘Multiple Shots on Goal’ with Current Pipeline [Proactive Investors]
April 7, 2021
David Johnson, Chairman and CEO of Enveric Biosciences [The Green Rush Podcast]
March 25, 2021
‹
1
…
8
9
10
11
12
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
